Cargando…
Acetylsalicylic Acid Effect in Colorectal Cancer Taking into Account the Role of Tobacco, Alcohol and Excess Weight
Excess weight, smoking and risky drinking are preventable risk factors for colorectal cancer (CRC). However, several studies have reported a protective association between aspirin and the risk of CRC. This article looks deeper into the relationships between risk factors and aspirin use with the risk...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001481/ https://www.ncbi.nlm.nih.gov/pubmed/36901115 http://dx.doi.org/10.3390/ijerph20054104 |
_version_ | 1784904147711033344 |
---|---|
author | Florensa, Didac Mateo, Jordi Solsona, Francesc Galván, Leonardo Mesas, Miquel Piñol, Ramon Espinosa-Leal, Leonardo Godoy, Pere |
author_facet | Florensa, Didac Mateo, Jordi Solsona, Francesc Galván, Leonardo Mesas, Miquel Piñol, Ramon Espinosa-Leal, Leonardo Godoy, Pere |
author_sort | Florensa, Didac |
collection | PubMed |
description | Excess weight, smoking and risky drinking are preventable risk factors for colorectal cancer (CRC). However, several studies have reported a protective association between aspirin and the risk of CRC. This article looks deeper into the relationships between risk factors and aspirin use with the risk of developing CRC. We performed a retrospective cohort study of CRC risk factors and aspirin use in persons aged >50 years in Lleida province. The participants were inhabitants with some medication prescribed between 2007 and 2016 that were linked to the Population-Based Cancer Registry to detect CRC diagnosed between 2012 and 2016. Risk factors and aspirin use were studied using the adjusted HR (aHR) with 95% confidence intervals (CI) using a Cox proportional hazard model. We included 154,715 inhabitants of Lleida (Spain) aged >50 years. Of patients with CRC, 62% were male (HR = 1.8; 95% CI: 1.6–2.2), 39.5% were overweight (HR = 2.8; 95% CI: 2.3–3.4) and 47.3% were obese (HR = 3.0; 95% CI: 2.6–3.6). Cox regression showed an association between aspirin and CRC (aHR = 0.7; 95% CI: 0.6–0.8), confirming a protective effect against CRC and an association between the risk of CRC and excess weight (aHR = 1.4; 95% CI: 1.2–1.7), smoking (aHR = 1.4; 95% CI: 1.3–1.7) and risky drinking (aHR = 1.6; 95% CI: 1.2–2.0). Our results show that aspirin use decreased the risk of CRC and corroborate the relationship between overweight, smoking and risky drinking and the risk of CRC. |
format | Online Article Text |
id | pubmed-10001481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100014812023-03-11 Acetylsalicylic Acid Effect in Colorectal Cancer Taking into Account the Role of Tobacco, Alcohol and Excess Weight Florensa, Didac Mateo, Jordi Solsona, Francesc Galván, Leonardo Mesas, Miquel Piñol, Ramon Espinosa-Leal, Leonardo Godoy, Pere Int J Environ Res Public Health Article Excess weight, smoking and risky drinking are preventable risk factors for colorectal cancer (CRC). However, several studies have reported a protective association between aspirin and the risk of CRC. This article looks deeper into the relationships between risk factors and aspirin use with the risk of developing CRC. We performed a retrospective cohort study of CRC risk factors and aspirin use in persons aged >50 years in Lleida province. The participants were inhabitants with some medication prescribed between 2007 and 2016 that were linked to the Population-Based Cancer Registry to detect CRC diagnosed between 2012 and 2016. Risk factors and aspirin use were studied using the adjusted HR (aHR) with 95% confidence intervals (CI) using a Cox proportional hazard model. We included 154,715 inhabitants of Lleida (Spain) aged >50 years. Of patients with CRC, 62% were male (HR = 1.8; 95% CI: 1.6–2.2), 39.5% were overweight (HR = 2.8; 95% CI: 2.3–3.4) and 47.3% were obese (HR = 3.0; 95% CI: 2.6–3.6). Cox regression showed an association between aspirin and CRC (aHR = 0.7; 95% CI: 0.6–0.8), confirming a protective effect against CRC and an association between the risk of CRC and excess weight (aHR = 1.4; 95% CI: 1.2–1.7), smoking (aHR = 1.4; 95% CI: 1.3–1.7) and risky drinking (aHR = 1.6; 95% CI: 1.2–2.0). Our results show that aspirin use decreased the risk of CRC and corroborate the relationship between overweight, smoking and risky drinking and the risk of CRC. MDPI 2023-02-24 /pmc/articles/PMC10001481/ /pubmed/36901115 http://dx.doi.org/10.3390/ijerph20054104 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Florensa, Didac Mateo, Jordi Solsona, Francesc Galván, Leonardo Mesas, Miquel Piñol, Ramon Espinosa-Leal, Leonardo Godoy, Pere Acetylsalicylic Acid Effect in Colorectal Cancer Taking into Account the Role of Tobacco, Alcohol and Excess Weight |
title | Acetylsalicylic Acid Effect in Colorectal Cancer Taking into Account the Role of Tobacco, Alcohol and Excess Weight |
title_full | Acetylsalicylic Acid Effect in Colorectal Cancer Taking into Account the Role of Tobacco, Alcohol and Excess Weight |
title_fullStr | Acetylsalicylic Acid Effect in Colorectal Cancer Taking into Account the Role of Tobacco, Alcohol and Excess Weight |
title_full_unstemmed | Acetylsalicylic Acid Effect in Colorectal Cancer Taking into Account the Role of Tobacco, Alcohol and Excess Weight |
title_short | Acetylsalicylic Acid Effect in Colorectal Cancer Taking into Account the Role of Tobacco, Alcohol and Excess Weight |
title_sort | acetylsalicylic acid effect in colorectal cancer taking into account the role of tobacco, alcohol and excess weight |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001481/ https://www.ncbi.nlm.nih.gov/pubmed/36901115 http://dx.doi.org/10.3390/ijerph20054104 |
work_keys_str_mv | AT florensadidac acetylsalicylicacideffectincolorectalcancertakingintoaccounttheroleoftobaccoalcoholandexcessweight AT mateojordi acetylsalicylicacideffectincolorectalcancertakingintoaccounttheroleoftobaccoalcoholandexcessweight AT solsonafrancesc acetylsalicylicacideffectincolorectalcancertakingintoaccounttheroleoftobaccoalcoholandexcessweight AT galvanleonardo acetylsalicylicacideffectincolorectalcancertakingintoaccounttheroleoftobaccoalcoholandexcessweight AT mesasmiquel acetylsalicylicacideffectincolorectalcancertakingintoaccounttheroleoftobaccoalcoholandexcessweight AT pinolramon acetylsalicylicacideffectincolorectalcancertakingintoaccounttheroleoftobaccoalcoholandexcessweight AT espinosalealleonardo acetylsalicylicacideffectincolorectalcancertakingintoaccounttheroleoftobaccoalcoholandexcessweight AT godoypere acetylsalicylicacideffectincolorectalcancertakingintoaccounttheroleoftobaccoalcoholandexcessweight |